Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
The International Journal of Biological Markers|February 24, 2022
Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?Juan Morote, Miriam Campistol, Lucas Regis, et al.
Molecular Diagnosis & Therapy|April 20, 2023
Relationship between Proclarix and the Aggressiveness of Prostate CancerMiriam Campistol, Marina Triquell, Lucas Regis, et al.
BJU International|August 14, 2012
Metabolic syndrome increases the risk of aggressive prostate cancer detectionJuan Morote, Jordi Ropero, Jacques Planas, et al.
BJU International|August 10, 2021
The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasiaJuan Morote, Iván Schwartzmann, Anna Celma, et al.
BJU International|October 17, 2013
Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude miceMarta Garcia, Roberto Velez, Cleofé Romagosa, et al.
World Journal of Urology|July 8, 2010
Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasiaJuan Morote, Marina Rigau, Marta Garcia, et al.
Scientific Reports|August 20, 2020
STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell populationGiacomo Canesin, Valentina Maggio, Macarena Palominos, et al.
The Prostate|July 31, 2010
PSGR and PCA3 as biomarkers for the detection of prostate cancer in urineMarina Rigau, Juan Morote, Maria Carmen Mir, et al.
Pageof 17